Optimizing intra-arterial hypothermia scheme for acute ischemic stroke in an MCAO/R rat model

Hypothermia is a promising neuroprotective treatment. This study aims to explore and optimize the intervention scheme of intra-arterial hypothermia (IAH) in a middle cerebral artery occlusion and reperfusion (MCAO/R) rat model. The MCAO/R model was established with a thread that could be retracted 2 h after occlusion. Cold normal saline was injected into the internal carotid artery (ICA) through a microcatheter in different infusion conditions. Grouping followed an orthogonal design (L-9[3(4)]) based on three critical factors closely associated with IAH: perfusate temperature (4, 10, 15 & DEG;C), infusion flow rate (1/3, 1/2, 2/3 blood flow rate of ICA), and duration (10, 20, 30 min), resulting in 9 subgroups (H-1, H-2 to H-9). A myriad of indexes were monitored, such as vital signs, blood parameters, changes in local ischemic brain tissue temperature (T-b), ipsilateral jugular venous bulb temperature (T-jvb), and the core temperature of the anus (T-core). After 24 h and 72 h of cerebral ischemia, cerebral infarction volume, cerebral water content, and neurological function were assessed to explore the optimal IAH conditions. The results revealed that the three critical factors were independent predictors for cerebral infarction volume, cerebral water content, and neurological function. The optimal perfusion conditions were 4 & DEG;C, 2/3 R-ICA (0.50 ml/min) for 20 min, and there was a significant correlation between T-b and T-jvb (R = 0.994, P < 0.001). The vital signs, blood routine tests and biochemical indexes showed no significant abnormal changes. These findings revealed that IAH was safe and feasible with the optimized scheme in an MCAO/R rat model.

Automated summary

This study aims to explore and optimize the intervention scheme of intra-arterial hypothermia (IAH) in a middle cerebral artery occlusion and reperfusion (MCAO/R) rat model. The results revealed that the optimal perfusion conditions were 4℃, 2/3 R-ICA (0.50 ml/min) for 20 minutes, and IAH was safe and feasible.